These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
251 related items for PubMed ID: 32596293
21. Randomized controlled trial of orchid drug-coated balloon versus standard percutaneous transluminal angioplasty for treatment of femoropopliteal artery in-stent restenosis. Liao CJ, Song SH, Li T, Zhang Y, Zhang WD. Int Angiol; 2019 Oct; 38(5):365-371. PubMed ID: 31566320 [Abstract] [Full Text] [Related]
22. Safety of Paclitaxel-Coated Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease. Ouriel K, Adelman MA, Rosenfield K, Scheinert D, Brodmann M, Peña C, Geraghty P, Lee A, White R, Clair DG. JACC Cardiovasc Interv; 2019 Dec 23; 12(24):2515-2524. PubMed ID: 31575518 [Abstract] [Full Text] [Related]
23. Drug-coated balloon angioplasty versus balloon angioplasty for treating patients with in-stent restenosis in the femoropopliteal artery: A meta-analysis. Cao S, He T, Xie J, Feng H, Liu K, Qu B, Wu X. Medicine (Baltimore); 2021 Apr 23; 100(16):e25599. PubMed ID: 33879723 [Abstract] [Full Text] [Related]
25. Drug-Coated Balloon Angioplasty for Femoropopliteal In-Stent Restenosis. Cassese S, Wolf F, Ingwersen M, Kinstner CM, Fusaro M, Ndrepepa G, Ibrahim T, Ott I, Lammer J, Krankenberg H, Fusaro M. Circ Cardiovasc Interv; 2018 Dec 23; 11(12):e007055. PubMed ID: 30562083 [Abstract] [Full Text] [Related]
28. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease. Scheinert D, Schmidt A, Zeller T, Müller-Hülsbeck S, Sixt S, Schröder H, Weiss N, Ketelsen D, Ricke J, Steiner S, Rosenfield K. J Endovasc Ther; 2016 Jun 23; 23(3):409-16. PubMed ID: 27117972 [Abstract] [Full Text] [Related]
31. Drug-Coated Balloon Angioplasty Compared With Uncoated Balloons in the Treatment of 200 Chinese Patients With Severe Femoropopliteal Lesions: 24-Month Results of AcoArt I. Xu Y, Jia X, Zhang J, Zhuang B, Fu W, Wu D, Wang F, Zhao Y, Guo P, Bi W, Wang S, Guo W. JACC Cardiovasc Interv; 2018 Dec 10; 11(23):2347-2353. PubMed ID: 30448170 [Abstract] [Full Text] [Related]
34. Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease. Caradu C, Lakhlifi E, Colacchio EC, Midy D, Bérard X, Poirier M, Ducasse E. J Vasc Surg; 2019 Sep 10; 70(3):981-995.e10. PubMed ID: 31126769 [Abstract] [Full Text] [Related]
37. Comparative effectiveness of endovascular treatment modalities for de novo femoropopliteal lesions in intermittent claudication: A network meta-analysis of randomized controlled trials. Zhou Y, Wang J, He H, Li Q, Li M, Li X, Shu C. Int J Cardiol; 2021 Nov 15; 343():122-130. PubMed ID: 34461162 [Abstract] [Full Text] [Related]
38. Drug-coated Balloon Angioplasty of Femoropopliteal Lesions Maintained Superior Efficacy over Conventional Balloon: 2-year Results of the Randomized EffPac Trial. Teichgräber U, Lehmann T, Aschenbach R, Scheinert D, Zeller T, Brechtel K, Blessing E, Lichtenberg M, von Flotow P, Heilmeier B, Sixt S, Brucks S, Erbel C, Beschorner U, Werk M, Riambau V, Wienke A, Klumb CT, Thieme M. Radiology; 2020 May 15; 295(2):478-487. PubMed ID: 32125256 [No Abstract] [Full Text] [Related]
39. Combination of RotarexⓇS Rotational Atherothrombectomy and Drug-Coated Balloonangioplasty for Femoropopliteal Total In-Stent Occlusion. Pan T, Tian SY, Liu Z, Zhang T, Li C, Ji DH. Ann Vasc Surg; 2022 Mar 15; 80():213-222. PubMed ID: 34748945 [Abstract] [Full Text] [Related]